Evidence map›Paper›PMID 32065691›Full record

ArticlePsycho-oncology2020

Decision regret in men living with and beyond nonmetastatic prostate cancer in the United Kingdom: A population-based patient-reported outcome study.

Sarah Wilding, Amy Downing, Peter Selby, William Cross, Penny Wright, Eila K Watson, Richard Wagland, Paul Kind, David W Donnelly, Luke Hounsome and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Psycho-oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
7.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Outcomes That Matter in Gastrointestinal Cancer Care: A Focus Group Study of Patient-Centred Outcomes Identified by Patients and Care Partners.Health expectations : an international journal of public participation in health care and health policy · 2026
    Article
  4. Article
  5. Decision regret in patients with rectal cancer undergoing multimodal therapy.Clinical and translational radiation oncology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 1 country.

Sarah WildingLeeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.ORCID 0000-0002-7977-7132
Amy DowningLeeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
Peter SelbyLeeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
William CrossLeeds Teaching Hospitals NHS Trust, University of Leeds, Leeds, UK.
Penny WrightLeeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
Eila K WatsonOxford Institute of Nursing, Midwifery and Allied Health Research, Oxford Brookes University, Oxford, UK.
Richard WaglandFaculty of Health Sciences, University of Southampton, Southampton, UK.
Paul KindAcademic Unit of Health Economics, University of Leeds, Leeds, UK.
David W DonnellyNorthern Ireland Cancer Registry, Queen's University Belfast, Belfast, UK.
Luke HounsomeNational Cancer Registration and Analysis Service, Public Health England, Bristol, UK.
Rebecca MottramLeeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
Majorie AllenLeeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
Therese KearneyNorthern Ireland Cancer Registry, Queen's University Belfast, Belfast, UK.
Hugh ButcherLeeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
Anna GavinNorthern Ireland Cancer Registry, Queen's University Belfast, Belfast, UK.
Adam GlaserLeeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
University of Leeds · GBQueen's University Belfast · GBOxford Brookes University · GBPublic Health England · GBUniversity of Southampton · GB

Funding

Department of HealthProstate Cancer UK BO26/MO
6 · The paper itself

Abstract

objectiveClinical options for managing nonmetastatic prostate cancer (PCa) vary. Each option has side effects associated with it, leading to difficulty in decision-making. This study aimed to assess the relationship between patient involvement in treatment decision-making and subsequent decision regret (DR), and quantify the impact of health-related quality of life (HRQL) outcomes on DR.

methodsMen living in the United Kingdom, 18 to 42 months after diagnosis of PCa, were identified from cancer registration data and sent a questionnaire. Measures included the Decision Regret Scale (DRS), Expanded Prostate cancer Index Composite short form (EPIC-26), EQ-5D-5L, and an item on involvement in treatment decision-making. Multivariable ordinal regression was utilized, with DR categorized as none, mild, or moderate/severe regret.

resultsA total of 17 193 men with stage I-III PCa completed the DRS: 36.6% reported no regret, 43.3% mild regret, and 20.0% moderate/severe regret. The odds of reporting DR were greater if men indicated their views were not taken into account odds ratio ([OR] = 6.42, 95% CI: 5.39-7.64) or were involved "to some extent" in decision-making (OR = 4.63, 95% CI: 4.27-5.02), compared with men who were "definitely" involved. After adjustment, including for involvement, men reporting moderate/big problems with urinary, bowel, or sexual function were more likely to experience regret compared with men with no/small problems. Better HRQL scores were associated with lower levels of DR.

conclusionsThis large-scale study demonstrates the benefit of patient involvement in treatment decision-making for nonmetastatic PCa. However, men experiencing side effects and poorer HRQL report greater DR. Promoting engagement in clinical decision-making represents good practice and may reduce the risk of subsequent regret.

Indexed as

Decision MakingPatient Reported Outcome MeasuresAdultAgedEmotionsHumansMaleMiddle AgedPatient ParticipationProstatic NeoplasmsQuality of LifeSurveys and QuestionnairesUnited Kingdomcancerdecision regretinvolvement in decision-makingLAPCDoncologypatient-reported outcomesprostate cancertreatment decision-making

Identifiers

PMID32065691
PMCPMC7317932
OpenAlexW3006469511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.